Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus
- 1 June 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (6) , 2223-2225
- https://doi.org/10.1128/aac.01410-07
Abstract
The ability of daptomycin to produce bactericidal activity against Staphylococcus aureus while causing negligible cell lysis has been demonstrated using electron microscopy and the membrane integrity probes calcein and ToPro3. The formation of aberrant septa on the cell wall, suggestive of impairment of the cell division machinery, was also observed.Keywords
This publication has 11 references indexed in Scilit:
- Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus CellsAntimicrobial Agents and Chemotherapy, 2007
- Prevention of Brain Injury by the Nonbacteriolytic Antibiotic Daptomycin in Experimental Pneumococcal MeningitisAntimicrobial Agents and Chemotherapy, 2007
- Minimizing the release of proinflammatory and toxic bacterial products within the host: A promising approach to improve outcome in life-threatening infectionsFEMS Immunology & Medical Microbiology, 2005
- Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Daptomycin: a novel lipopeptide antibioticClinical Microbiology Newsletter, 2002
- The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolatesJournal of Antimicrobial Chemotherapy, 2001
- CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activityJournal of Immunological Methods, 1994
- Scanning Electronmicroscopy of Staphylococcus Aureus and Enterococcus Faecalis Exposed to DaptomycinJournal of Medical Microbiology, 1989
- Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY 146032 and phospholipid membranesBiochemistry, 1988
- Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against Gram-positive organismsJournal of Antimicrobial Chemotherapy, 1987